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Abstract Uroporphyrinogen III synthase from the cyanobacte-
rium Anacystis nidulans was overproduced in Escherichia coli
and analyzed by site speci¢c mutagenesis. Of the nine conserved
amino acids altered, only a single tyrosine mutant (Y166F)
showed any signi¢cant decrease in activity suggesting this
residue is critical for proper substrate binding and/or
catalysis. & 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Uroporphyrinogen III (urogen III), the common precursor
to the ‘pigments of life’ heme, siroheme, chlorophyll, cobala-
min and factor F430, is derived by the enzymatic cyclization
and rearrangement of the D ring of hydroxymethylbilane
(HMB) by urogen III synthase (U3S) (reviewed in [1]) whilst
non-enzymatic cyclization of HMB without rearrangement
results in the non-functional isomer, urogen I (Fig. 1). The
structure of human U3S has recently been reported [2] accom-
panied by a mutagenic study which suggested that, since no
catalytic amino acid residue could be identi¢ed among those
conserved in homologous enzymes, U3S functions simply by
holding the substrate in a conformation favorable to urogen
III formation.
The favored mechanism for the synthesis of urogen III fea-
tures a spiro intermediate (Fig. 1) in which the enzyme func-
tions to hold HMB in a con¢guration favorable to urogen III
formation and to provide a proton source to facilitate azaful-
vene formation by removal of the hydroxyl group at C-20.
Indeed, azafulvene formation and cyclization to a¡ord urogen
I occur at physiological and slightly alkaline pH but the en-
zymatic reaction leading to urogen III is much faster [1]. In
addition, azafulvene formation at C-20 is absolutely depen-
dent on U3S at pH 10.8 using puri¢ed Escherichia coli enzyme
which lends support to a role more than just structural for the
catalytic activity [3].
We report here the overproduction of U3S from Anacystis
nidulans and the requirement of a conserved tyrosine residue
for optimal activity of the enzyme.
2. Materials and methods
2.1. Materials
Porphobilinogen (PBG) was purchased from Sigma. PBG deami-
nase (speci¢c activity= 25 U/mg) was puri¢ed free from U3S activity
as previously described [4]. I2/trichloroacetic acid (TCA) solution was
made by dissolving 25 mg of I2 and 50 mg of KI in 5.0 ml of 10%
TCA. PCR primers and sequencing services were provided by the
Gene Technologies Laboratory, Biology Department, TAMU. Pfu-
Turbo polymerase was purchased from Stratagene. Restriction en-
zymes and T4 DNA ligase were from New England Biolabs. The
expression vector pET28a was purchased from Novagen.
2.2. Overproduction and puri¢cation of A. nidulans U3S
A. nidulans U3S was overproduced with a 6UHis-tag to facilitate
puri¢cation by ligating a PCR product containing the A. nidulans
hemD gene [5] into pET28a using the NheI and HindIII restriction
sites and transformation of the resultant plasmid into E. coli strain
BL21DE3 to a¡ord strain CR586. The sequence of the forward PCR
primer was CGC GCG GCT AGC ATG GCT GAG CAG CCG
CTG ATC GGT AAA ACC which provided the NheI site (under-
lined) and the ¢rst 10 codons of the A. nidulans hemD gene. The
sequence of the reverse primer was CTG CAG AAG CTT TTA
CTG GGT TTG GCG CGC CCA TTG TTC GAT CGC which
provided the HindIII site (underlined), a stop anticodon (bold), and
the anticodons of the last 10 amino acids. The PCR product was
generated and ligated into pET28a using standard procedures [6].
For expression of U3S and mutant enzymes, the strains were grown
with good aeration at 37‡C in LB medium containing 50 Wg/ml ka-
namycin to an A600 of 0.8, induced by addition of 0.4 mM IPTG and
incubated at 25‡C for 16 h. Production of the protein at 37‡C resulted
in accumulation of the protein in insoluble inclusion bodies. The cells
were collected by centrifugation, resuspended in lysis bu¡er (20 mM
Tris^HCl, pH 8.0, 100 mM NaCl) and lysed by sonication. The lysate
was centrifuged at 10 000Ug for 10 min and U3S was puri¢ed from
the supernatant (soluble fraction) via the N-terminal His-tag provided
by pET28a using Talon resin (Clontech) and following instructions
given by the supplier. Protein purity and solubility were monitored by
SDS^PAGE using the system of Laemmli [7].
2.3. Mutagenesis of the A. nidulans hemD gene
U3S mutants were constructed using the QuikChange1 site-di-
rected mutagenesis procedure (Stratagene). Presence of the mutations
and the integrity of the rest of the gene were con¢rmed by sequencing.
2.4. U3S assay
U3S activity was monitored by the production of urogen III as
determined by a modi¢ed lag assay [8]. For each reaction, 50 Wl
PBG deaminase and 50 Wl of U3S-containing solution (lysate or pu-
ri¢ed enzyme) were mixed and preincubated for 1 min at 37‡C. 50 Wl
of PBG (0.2 mg/ml at 37‡C) was added to start the reaction. After
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1 min, 150 Wl of I2/TCA was added to stop the reaction and oxidize
urogens to uroporphyrins (uros). After 4.0 min at room temperature,
5.0 Wl of saturated sodium metabisul¢te was added to quench excess
I2, and the solution was centrifuged for 1 min in a microfuge. The
supernatant was diluted 20-fold with 1.0 N HCl and the absorbance
measured at 405 nm. A background value, determined from a control
sample of 50 Wl of bu¡er without U3S, was subtracted from the
sample A405 and the amount of urogen III synthesized calculated
from the di¡erence using E=518 000 M31 cm31 for the extinction
coe⁄cient of uros in HCl. Alternatively, the products were analyzed
by high-performance liquid chromatography (HPLC) separation of
the uro isomers in the free acid form [9]. One unit is de¢ned as
the amount of U3S required to synthesize 1.0 nmol of urogen III in
1 min.
3. Results and discussion
Based on the nucleotide sequence of the A. nidulans hemD
gene and the corresponding amino acid sequence for U3S
(Fig. 2) [5], a vector for the overexpression of the gene in
E. coli was constructed which a¡orded high levels of active
wild-type U3S (Fig. 3, Table 1). Site-directed mutagenesis
provided mutants of the amino acid residues most highly con-
served among homologous U3S enzymes (R15Q, S68A, T100A,
D112G, Y166F, and S194A, Fig. 2). The relative activities
of soluble cell fractions containing the wild-type or mutant
enzymes were determined with the lag assay (Table 1). In
this coupled assay, the substrate, HMB, is generated from
PBG and PBG deaminase and is partially consumed by
non-enzymatic cyclization during the reaction (Fig. 1). There-
fore, care must be taken that substrate does not become limit-
ing. Thus, rather than using a single enzyme concentration, a
series of dilutions of the soluble cell fractions were tested and
the highest dilution still showing signi¢cant activity over back-
ground was chosen to estimate relative activity. This assay
indicated that only the alteration Y166F had any signi¢cant
e¡ect on the activity of the enzyme (Table 1). To con¢rm this
¢nding, the wild-type and Y166F mutants were puri¢ed and
the speci¢c activity of each determined with the lag assay (Fig.
3, Table 1). In a separate experiment, HPLC analysis of the
reaction products [9] gave a higher speci¢c activity for both
Fig. 1. The proposed mechanism for the biosynthesis of urogen III from HMB by U3S featuring a spiro intermediate.
Fig. 2. Amino acid sequence of U3S from A. nidulans. The residues
that were altered for this work are shown in bold.
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the wild-type enzyme (160 000 U/mg) and the Y166F mutant
enzyme (2660 U/mg). While the Y166F mutant enzyme is not
completely inactive, the speci¢c activity of the puri¢ed enzyme
was only 0.6^1.6% of that of the puri¢ed wild-type enzyme
indicating that this tyrosine residue is essential for activity,
either by directing the binding of the substrate in the correct
conformation or by providing a functional group for catalysis,
or both. If the latter is the case, this result is somewhat sur-
prising because tyrosine is not generally considered a good
proton donor as are lysine and arginine. However, mutating
the only conserved arginine (R15, which is functionally con-
served as a lysine in some organisms) to glutamine had no
e¡ect on enzyme activity. T229 and at least one of three
closely clustered arginines of A. nidulans U3S (R135, R140
and R146) are also found in U3S of most other organisms,
but R135Q, R140Q, R146Q and T229A mutants retained 50^
100% of the wild-type activity (not shown).
Some of the mutations apparently caused misfolding of the
protein (e.g. S68A and, especially, S194A) since they were less
soluble, but Y166F remains as soluble as wild-type U3S (Fig.
3). The soluble S68A and S194A, however, maintain activity
(Table 1).
The above results are consistent with the previously re-
ported mutagenic study of human U3S with the exception
of the greatly reduced activity of the Y166F mutant. The
analogous mutant of human U3S (Y168F) apparently re-
tained about 50% of the activity of the wild-type enzyme
[2]. This result may be misleading, however, since substrate
may have been limiting in the assay described to monitor the
activity of this enzyme.
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Table 1
Lag assay results for determination of the activity of A. nidulans U3S mutants relative to wild-type enzyme
Fold dilution of cell extracta Relative activity (%)b
10 100 200 400 800 1600
w.t. ^ 5.3 5.3 5.9 4.7 3.4 100
R15Q ^ 5.6 5.8 6.0 5.5 5.3 v 100
S68A ^ 5.5 5.5 4.6 3.0 ^ v 100
T100A ^ 5.5 4.8 4.0 2.7 ^ 25
D112G ^ 5.3 5.5 5.3 3.7 ^ 50
S194A 5.9 2.7 ^ ^ ^ ^
blank 1.7 1.4 1.4 1.8 1.8 2.1
Fold dilution of cell extracta Relative activity (%)b
10 20 50 100 400 800 1600 100
w.t. ^ ^ ^ 6.0 5.6 5.9 4.6
Y166F 4.0 3.5 2.5 2.8 ^ ^ ^ 6 1
blank 2.3 2.3 2.1 2.1 2.5 2.5 2.5
Fold dilution of puri¢ed enzymec Speci¢c activity
0 10 100 400 800
w.t. (0.32 mg/ml) ^ 5.5 5.5 3.9 3.0 40 000 U/mgd
Y166F (0.40 mg/ml) 3.7 2.8 2.8 ^ ^ 250 U/mge
blank 2.3 2.3 2.8 2.3 2.3
Values shown are nmol of urogens synthesized per assay.
aSoluble fraction shown in Fig. 3.
bDetermined from the highest dilution showing signi¢cant di¡erence from the blank and estimating the relative amount of soluble enzyme in
the extract (Fig. 2).
cPuri¢ed wild-type (WT) and Y166F mutant enzyme shown in Fig. 3.
dCalculated from the 400-fold dilution.
eCalculated from the 10-fold dilution.
Fig. 3. SDS^PAGE determination of the relative levels of produc-
tion and solubility of wild-type and mutant U3S enzymes. Also
shown (bottom gel) are wild-type and Y166F enzymes puri¢ed by a
single step batch metal a⁄nity procedure. WT, wild-type; L, whole
cell lysate; S, soluble fraction; MW, molecular weight markers from
the top: 66K, 45K, 36K, 29K, 24K, 14K.
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